141
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection

, , , , , , , & show all
Pages 253-255 | Received 22 May 2021, Accepted 30 Aug 2021, Published online: 15 Sep 2021
 

Acknowledgement

REGN-COV2 (cocktail of two antibodies, casirivimab and imdevimab) was provided by Regeneron Pharmaceuticals, Inc. for the purpose of emergency compassionate use treatment

Ethical statement

First patient was not able to sign a written informed consent, his wife have accepted that his medical information’s was published. Two others patients signed a written informed consent.

The use of data was approved by Erasme University Hospital ethics committee

Author contributions

AP: Conceptualization, writing original draft, GV, NY, CM: Data curation, reviewing MH, DG, VDW, MC: reviewing, editing.

Disclosure statement

The authors declare no conflict of interest

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.